T Kitagawa

Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder

Takeshi Inoue, Kiyofumi Sasai, T Kitagawa et al. · Psychiatry and Clinical Neurosciences · 2019 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

Akira Nishimura, Yutaka Aritomi, Kiyofumi Sasai et al. · Psychiatry and Clinical Neurosciences · 2017 · 46 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan

Nobutaka Hattori, Atsushi Takeda, Shin‐ichi Takeda et al. · Parkinsonism & Related Disorders · 2018 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer

Hiroyoshi Suzuki, Hiroji Uemura, Atsushi Mizokami et al. · Cancer Medicine · 2019 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Randomized, 8‐week, double‐blind, placebo‐controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52‐week open‐label extension trial

Takeshi Inoue, Akira Nishimura, Kiyofumi Sasai et al. · Psychiatry and Clinical Neurosciences · 2017 · 27 citations · Full text

Medicine, Pharmacology, Psychiatry +17